Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy

Journal of the American College of Cardiology

Volumn 64, Issue 10, 2014, Pages 971-981

  Ruwald, Martin H ^a,b   Mittal, Suneet ^c,d   Ruwald, Anne Christine ^a,b   Aktas, Mehmet K ^a   Daubert, James P ^e   McNitt, Scott ^a   Al Ahmad, Amin ^f   Jons, Christian ^b   Kutyifa, Valentina ^a   Steinberg, Jonathan S ^c,d   Wang, Paul ^g   Moss, Arthur J ^a   Zareba, Wojciech ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Valley Health System of New York   (United States)

^d Arrhythmia Institute Valley Health System of New Jersey   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f Texas Cardiac Arrhythmia Research   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biventricular pacing; Cardiac resynchronization therapy; Ectopic beats; Holter monitoring; Prognosis; Reverse remodeling

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; FEMALE; HEART FAILURE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUPRAVENTRICULAR PREMATURE BEAT; AGE DISTRIBUTION; AGED; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ECTOPIC BEATS; ELECTROCARDIOGRAPHY; HOLTER MONITORING; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; REVERSE REMODELING; RISK; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX RATIO; SURVIVAL RATE; TREATMENT OUTCOME;

BIVENTRICULAR PACING; CARDIAC RESYNCHRONIZATION THERAPY; ECTOPIC BEATS; HOLTER MONITORING; PROGNOSIS; REVERSE REMODELING;

AGE DISTRIBUTION; AGED; ATRIAL PREMATURE COMPLEXES; CARDIAC RESYNCHRONIZATION THERAPY; CONFIDENCE INTERVALS; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR PREMATURE COMPLEXES;

EID: 84908160420     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.06.1177     Document Type: Article

References (25)

1. Moss AJ, Hall WJ, Cannom DS, et al., for the MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
2. Bristow MR, Saxon LA, Boehmer J, et al., for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350: 2140-20.
3. Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol 2009;53:355-60.
4. Kamath GS, Cotiga D, Koneru JN, et al. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. J Am Coll Cardiol 2009;53: 1050-5.
5. Hayes DL, Boehmer JP, Day JD, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 2011;8:1469-75.
6. Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for devicebased therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2013;61:e6-75.
7. Gasparini M, Auricchio A, Regoli F, et al. Fouryear efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006;48:734-43.
8. Gasparini M, Galimberti P, Ceriotti C. The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy. Curr Opin Cardiol 2013;28:50-4.
9. Mullens W, Grimm RA, Verga T, et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol 2009;53:765-73.
10. Cheng A, Landman SR, Stadler RW. Reasons for loss of cardiac resynchronization therapy pacing: insights from 32 844 patients. Circ Arrhythm Electrophysiol 2012;5:884-8.
11. Moss AJ, Brown MW, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADITCRT): design and clinical protocol. Ann Noninvasive Electrocardiol 2005;10:34-43.
12. Ruwald AC, Kutyifa V, Ruwald MH, et al. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy. Eur Heart J 2014 [E-pub ahead of print]; http://dx.doi.org/10.1093/eurheartj/ehu294.
13. Ruwald MH, Ruwald AC, Jons C, et al. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J Am Coll Cardiol 2013;61:1518-26.
14. Anastasiou-Nana M, Menlove RL, Mason J, for the Western Enoximone Study Group. Quantification of prevalence of asymptomatic ventricular arrhythmias in patients with heart failure. Ann Noninvasive Electrocardiol 1997;2:346-53.
15. Bardy GH, Lee KL, Mark DB, et al., for the Sudden Cardiac Death in Heart Failure (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
16. Singh SN, Fisher SG, Carson PE, Fletcher RD. Department of Veterans Affairs CHF STAT Investigators. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. J Am Coll Cardiol 1998;32:942-7.
17. Doval HC, Nul DR, Grancelli HO, et al., for the GESICA-GEMA Investigators. Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. Circulation 1996;94:3198-203.
18. Iacoviello M, Forleo C, Guida P, et al. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2007;50:225-31.
19. Grimm W, Christ M, Maisch B. Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 2005;28 Suppl 1:S207-10.
20. Fauchier L, Douglas J, Babuty D, Cosnay P, Fauchier JP. QT dispersion in nonischemic dilated cardiomyopathy: a long-term evaluation. Eur J Heart Fail 2005;7:277-82.
21. Binici Z, Intzilakis T, Nielsen OW, Kober L, Sajadieh A. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 2010;121:1904-11.
22. Melenovsky V, Hay I, Fetics BJ, et al. Functional impact of rate irregularity in patients with heart failure and atrial fibrillation receiving cardiac resynchronization therapy. Eur Heart J 2005;26: 705-11.
23. Khadjooi K, Foley PW, Chalil S, et al. Longterm effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart 2008;94: 879-83.
24. Boriani G, Gasparini M, Landolina M, et al., and on behalf of the ClinicalService cardiac centres. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy. Eur J Heart Fail 2011;13: 868-76.
25. Goldenberg I, Moss AJ, Hall WJ, et al. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011;124: 1527-36.